Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17303 | 542 | 37.5 | 73% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 120 | 23422 | GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//INSULIN LIKE GROWTH FACTOR I |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CC MORFOL FISIOL | Address | 4 | 67% | 1% | 4 |
| 2 | SCI POLYMER TECHNOL | Address | 2 | 67% | 0% | 2 |
| 3 | MAC25 | Author keyword | 1 | 25% | 1% | 3 |
| 4 | INSULIN LIKE GROWTH FACTOR BINDING PROTEINS 1 AND 3 | Author keyword | 1 | 33% | 0% | 2 |
| 5 | ARSBARC E | Address | 1 | 50% | 0% | 1 |
| 6 | CANC PALLIAT MED | Address | 1 | 50% | 0% | 1 |
| 7 | CATABOLIC ILLNESS | Author keyword | 1 | 50% | 0% | 1 |
| 8 | DORSAL SKIN RESPONSES | Author keyword | 1 | 50% | 0% | 1 |
| 9 | DYSOVULATION | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ENDOTOXIN CYTOKINES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | POSITIVE NITROGEN BALANCE | 20 | 66% | 4% | 19 |
| 2 | CATABOLIC RESPONSE | 7 | 39% | 3% | 14 |
| 3 | BODY NITROGEN ECONOMY | 5 | 63% | 1% | 5 |
| 4 | DIFFERENTIAL TISSUE REGULATION | 3 | 100% | 1% | 3 |
| 5 | PROTRACTED CRITICAL ILLNESS | 3 | 24% | 2% | 10 |
| 6 | HEPATOCYTE PRIMARY CULTURE | 2 | 44% | 1% | 4 |
| 7 | MAJOR GASTROINTESTINAL SURGERY | 2 | 67% | 0% | 2 |
| 8 | FREE GLUTAMINE | 2 | 31% | 1% | 5 |
| 9 | GUT ATROPHY | 1 | 50% | 0% | 2 |
| 10 | PLATE CHONDROPROGENITOR CELLS | 1 | 50% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Is there a role for growth hormone therapy in refractory critical illness? | 2008 | 11 | 40 | 43% |
| Safety aspects of pharmacological GH therapy in adults | 2001 | 13 | 22 | 59% |
| Growth hormone therapy for protein catabolism | 1996 | 32 | 41 | 54% |
| The inflammatory response to surgery and trauma | 2006 | 54 | 56 | 13% |
| STRATEGIES FOR ATTENUATING PROTEIN-CATABOLIC RESPONSES IN THE CRITICALLY ILL | 1994 | 49 | 48 | 48% |
| Hormonal and metabolic strategies to attenuate catabolism in critically ill patients | 2004 | 17 | 69 | 30% |
| ACQUIRED GROWTH-HORMONE RESISTANCE | 1995 | 55 | 55 | 31% |
| Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury | 2006 | 11 | 101 | 31% |
| Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation | 1999 | 82 | 102 | 24% |
| Growth hormone and insulin-like growth factors in critical illness | 1997 | 19 | 68 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CC MORFOL FISIOL | 4 | 67% | 0.7% | 4 |
| 2 | SCI POLYMER TECHNOL | 2 | 67% | 0.4% | 2 |
| 3 | ARSBARC E | 1 | 50% | 0.2% | 1 |
| 4 | CANC PALLIAT MED | 1 | 50% | 0.2% | 1 |
| 5 | NEUROANAT CELLULAR BIOL | 1 | 50% | 0.2% | 1 |
| 6 | UNITAT CU INTENS PEDIAT | 1 | 50% | 0.2% | 1 |
| 7 | DIABET NUTR UNIT | 1 | 17% | 0.6% | 3 |
| 8 | FIRUZGAR HOSP | 0 | 33% | 0.2% | 1 |
| 9 | NUTRIT PATHOL | 0 | 33% | 0.2% | 1 |
| 10 | RADYASYON ONKOL ABD | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000269340 | HYPERMETABOLISM//GALVESTON BURNS UNIT//HYPERMETABOLIC RESPONSE |
| 2 | 0.0000148599 | DIPARTIMENTO SCI MED DIAGNOST//HEPATOL 5//PL MOL MED IMMA BOADILLA DEL MONTE |
| 3 | 0.0000136185 | MECHANO GROWTH FACTOR//MECHANO GROWTH FACTOR MGF//IGF 1 ISOFORMS |
| 4 | 0.0000129969 | BIOMED SURG CELL BIOL//MED CHILDRENS CLIN//RHIGF I THERAPY |
| 5 | 0.0000113574 | HEPATIC AMINO NITROGEN CONVERSION//UREA SYNTHESIS//AMMONIOGENESIS |
| 6 | 0.0000111261 | IGFBP 5//INSULIN LIKE GROWTH FACTOR BINDING PROTEIN//IGFBP 3 |
| 7 | 0.0000109611 | EDWARD R MADIGAN 207//BIOACTIVE PROLACTIN//THYMUS |
| 8 | 0.0000104135 | GROWTH HORMONE DEFICIENCY//ADULT GH DEFICIENCY//ADULT GROWTH HORMONE DEFICIENCY |
| 9 | 0.0000098022 | POSTOPERATIVE FATIGUE SYNDROME//VITAMIN Q//POSTOPERATIVE FATIGUE |
| 10 | 0.0000096636 | INFUSIONSTHERAPIE UND KLINISCHE ERNAHRUNG//HYPOCALORIC PARENTERAL NUTRITION//METABOLIC MONITOR |